Optimal dose of etanercept in the treatment of rheumatoid arthritis
Elizabeth Mary Curtis, Jonathan Lewis MarksDepartment of Rheumatology, University Hospital Southampton, Southampton, Hampshire, UKAbstract: Etanercept (ETN) is one of a number of biological therapies targeting the proinflammatory cytokine tumor necrosis factor-alpha that have demonstrated efficacy...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2014-03-01
|
| Series: | Open Access Rheumatology : Research and Reviews |
| Online Access: | http://www.dovepress.com/optimal-dose-of-etanercept-in-the-treatment-of-rheumatoid-arthritis-a16197 |